Sirnaomics Ltd (2257.HK)

Name: Sirnaomics Ltd Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2026-04-08

Latest Quarter

2026-04-08

Revenue

$81.0K

Net Income

-$3.7M

Operating Margin

-6,811.1%

Free Cash Flow

-$19.8M

Debt / Assets

156.5%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Sirnaomics Ltd (2257.HK).
Income Statement (Quarterly)	2026-04-08	2025-06-30	2025-03-31	2024-12-31
Revenue	81,000	81,000	40,500	434,000
Cost of Revenue	0	0	0	289,500
Gross Profit	81,000	81,000	40,500	144,500
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	2,553,000	2,553,000	1,276,500	3,500,500
Operating Expenses	5,598,000	5,598,000	2,799,000	6,776,000
Operating Income	-5,517,000	-5,517,000	-2,758,500	-6,631,500
Interest Expense	0	394,000	0	0
Income Before Tax	-3,388,000	-3,388,000	-1,694,000	-3,376,000
Income Tax Expense	0	0	0	0
Net Income	-3,698,000	-3,698,000	-1,849,000	-5,159,000
Per Share
EPS	-0.04	-0.04	-0.02	-0.07
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Sirnaomics Ltd (2257.HK).
Income Statement (Annual)	2024-12-31	2023-12-31	2022-12-31
Revenue	1,778,000	397,000	0
Cost of Revenue	579,000	0	0
Gross Profit	1,199,000	397,000	0
Operating Expenses
R&D Expenses	0	0	0
SG&A Expenses	17,161,000	23,161,000	24,191,000
Operating Expenses	37,963,000	77,543,000	91,153,000
Operating Income	-36,764,000	-77,146,000	-96,548,000
Interest Expense	1,049,000	0	798,000
Income Before Tax	-50,245,000	-84,990,000	-97,378,000
Income Tax Expense	0	0	-9,079,000
Net Income	-51,383,000	-78,691,000	-88,299,000
Per Share
EPS	-0.66	-1.03	-1.16
EPS Diluted	0.00	0.00	0.00

Balance sheet quarterly history for Sirnaomics Ltd (2257.HK).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	11,769,000	23,884,000	105,229,000
Short Term Investments	0	20,043,000	0
Net Receivables	0	0	0
Inventory	0	0	0
Total Current Assets	19,459,000	58,718,000	117,249,000
Property Plant Equipment	7,621,000	15,484,000	29,522,000
Goodwill and Intangibles	730,000	823,000	919,000
Total Assets	28,329,000	75,787,000	163,931,000
Liabilities
Account Payables	4,599,000	3,868,000	4,892,000
Short Term Debt	951,000	1,179,000	1,751,000
Total Current Liabilities	37,226,000	13,013,000	14,227,000
Long Term Debt	7,107,000	7,666,000	9,005,000
Total Liabilities	44,333,000	51,330,000	52,371,000
Shareholders Equity
Retained Earnings	-524,022,000	-472,639,000	-394,325,000
Total Shareholders Equity	-1,680,000	40,196,000	122,006,000

Balance sheet annual history for Sirnaomics Ltd (2257.HK).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	11,769,000	23,884,000	105,229,000
Short Term Investments	0	20,043,000	0
Net Receivables	0	0	0
Inventory	0	0	0
Total Current Assets	19,459,000	58,718,000	117,249,000
Property Plant Equipment	7,621,000	15,484,000	29,522,000
Goodwill and Intangibles	730,000	823,000	919,000
Total Assets	28,329,000	75,787,000	163,931,000
Liabilities
Account Payables	4,599,000	3,868,000	4,892,000
Short Term Debt	951,000	1,179,000	1,751,000
Total Current Liabilities	37,226,000	13,013,000	14,227,000
Long Term Debt	7,107,000	7,666,000	9,005,000
Total Liabilities	44,333,000	51,330,000	52,371,000
Shareholders Equity
Retained Earnings	-524,022,000	-472,639,000	-394,325,000
Total Shareholders Equity	-1,680,000	40,196,000	122,006,000

Cash flow quarterly history for Sirnaomics Ltd (2257.HK).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-51,383,000	-78,691,000	-97,378,000
Depreciation & Amortization	5,556,000	6,159,000	3,933,000
Stock Based Compensation	2,666,000	3,550,000	413,000
Change in Working Capital	7,108,000	-2,740,000	-1,232,000
Operating Cash Flow	-19,728,000	-70,292,000	-88,708,000
Investing Activities
Capital Expenditure	-108,000	-1,742,000	-18,830,000
Investments	0	-1,742,000	-18,830,000
Investing Cash Flow	2,138,000	-5,350,000	-32,611,000
Financing Activities
Debt Repayment	-1,059,000	0	0
Common Stock Issued/Repurchased	7,520,000	-5,432,000	72,000
Dividends Paid	0	0	0
Financing Cash Flow	5,817,000	-5,606,000	15,888,000
Summary
Free Cash Flow	-19,836,000	-72,034,000	-107,538,000
Net Change in Cash	-12,115,000	-81,345,000	-106,765,000

Cash flow annual history for Sirnaomics Ltd (2257.HK).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-51,383,000	-78,691,000	-97,378,000
Depreciation & Amortization	5,556,000	6,159,000	3,933,000
Stock Based Compensation	2,666,000	3,550,000	413,000
Change in Working Capital	7,108,000	-2,740,000	-1,232,000
Operating Cash Flow	-19,728,000	-70,292,000	-88,708,000
Investing Activities
Capital Expenditure	-108,000	-1,742,000	-18,830,000
Investments	0	-1,742,000	-18,830,000
Investing Cash Flow	2,138,000	-5,350,000	-32,611,000
Financing Activities
Debt Repayment	-1,059,000	0	0
Common Stock Issued/Repurchased	7,520,000	-5,432,000	72,000
Dividends Paid	0	0	0
Financing Cash Flow	5,817,000	-5,606,000	15,888,000
Summary
Free Cash Flow	-19,836,000	-72,034,000	-107,538,000
Net Change in Cash	-12,115,000	-81,345,000	-106,765,000